Breztri
Payments companies reported to CMS as associated with Breztri. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Breztri, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Breztri
These are the largest totals companies reported as associated with Breztri. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Kenneth Lander | Upland, PA | Pulmonary Disease | $477,093.23 |
| Domenick Reina | Tampa, FL | Pulmonary Disease | $452,998.27 |
| Manuel Cunanan | Millville, NJ | Pulmonary Disease | $308,464.82 |
| Salman Fidahussein | Lagrange, GA | Critical Care Medicine (Internal Medicine) | $289,565.73 |
| Alan Kanouff | Altoona, PA | Pulmonary Disease | $273,453.90 |
| George Parides | Mesa, AZ | Pulmonary Disease | $272,993.41 |
| Demondes Haynes | Jackson, MS | Pulmonary Disease | $253,733.17 |
| Ryan Martin | Lincoln, NE | Pulmonary Disease | $249,469.13 |
| Omar Minai | Hopewell, VA | Pulmonary Disease | $229,606.44 |
| David Pham | Westminster, CA | Pulmonary Disease | $216,622.56 |
Prescribed Breztri?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.